Summary We studied the incidence of intracranial tumours in Lothian Region in south-east Scotland in 1989-90. Among 106 patients resident in the Region, 60 (57%) were of working age (15-64 years). All but two cases (97%) were histologically confirmed. The average annual incidence of cerebral glioma in this age range was 5.9 (95% CI 3.8 -8.0) per 100 000 per year. Cerebral glioma will affect approximately 2100 people of working age in the UK every year. 
Cancer is the leading cause of death in people under 65 years of age in Scotland (The Scottish Office, Home and Health Department, 1991) . In 1992 a government policy document proposed targeting patients under the age of 65 years to reduce cancer deaths by 15% by the year 2000 (Scottish Office, Home and Health Department, 1993) . To achieve this aim, an advisory committee was established and nine common cancers were selected for special attention (breast, lung, colon, bladder, prostate, ovary, cervix, uterus and stomach) (Aitken et al., 1994) . Brain tumours were not included.
There are no up-to-date UK incidence figures for cerebral glioma in the adult population of working age. The commonly quoted average annual incidence of 3.94 per 100 000 population per year was estimated at a time when computerised tomographic (CT) scanning was not available , and was based on referrals to a specialist regional neuroscience unit (Barker et al., 1976 
Results
The audit identified a total of 579 incident cases of intracranial tumour in the 2 years 1989-90 in south-east Scotland. Of these, 153 (18.3%) were patients with cerebral glioma. A total of 106 (69.3%) of these patients were from Lothian Region (EH post code) and 60 patients (57%) were aged between 15-64 years. Fifty-eight patients (97%) had histological confirmation of the diagnosis; one patient with a CT diagnosis of a low-grade glioma was still alive at 31 December 1993, and another, whose CT scan was consistent with glioblastoma multiforme, had a poor performance status at diagnosis and died 57 days after her CT scan.
The average annual incidence of cerebral glioma in the 15-64 year age range in Lothian Region was 5.9 per 100 000 per year (95% CI 3.8-8.0). Age-specific incidence rates are shown in Sharp et al., 1993) .
We found that the average annual incidence for cerebral glioma in the population of working age was 5.9 per 100 000, with the highest incidence in the 60-64 age group (12.0 per 100 000). Barker reported the incidence of adult glioma (over the age of 15 years) in Southern England as 3.9 per 100 000 per year (Barker et al., 1976) , and this figure is still commonly cited in recent editions of UK textbooks on neuro-oncology (McKeran et al., 1990) . The lower incidence rate could be accounted for by the single institution nature of the earlier study and the fact that it was in pre-CT scanning days. Average annual incidence rates of brain tumours at all ages in England and Wales between 1981 and 1984 are reported as 3.60 per 100 000 for males and 5.25 per 100 000 for females (Ben Shlomo and Davey Smith, 1989) . Some 62% of the population are in the working age range (males 16-64, females 16-59) (K Dargie, personal communication). Based on an incidence rate of 5.9 per 100 000 per year and a UK population of 57.41 million, one would expect about 2100 new cases of cerebral glioma each year in the population of working age.
The high incidence of glioma reported here is likely to be due in part to better ascertainment of cases. It could also be due either to a genuinely higher regional incidence in Lothian or to an increase in incidence of glioma over the last two decades. There does appear to have been an increase of 1-2% a year in the incidence of brain tumours over the past 30 years in many countries (Muir et al., 1994) , and this increase may be significantly higher in the elderly (Greig et al., 1990) . The extent to which these increases in incidence are due to improved case ascertainment remains uncertain.
Cancer co-ordinating bodies may not perceive cerebral glioma as a common cancer in the working population because, at present, even in a centre with a specialist interest in neuro-oncology, only two-thirds of patients receive cranial irradiation and only one in six receives chemotherapy. Glioma is a common cause of cancer death in the working population. Malignant brain tumours rank as the fifth most common cause of death from solid malignancy under the age of 65 years, only cancers of the lung, breast, colon and oesophagus being more common. As a cause of death in this age group, they are slightly more common than cancers of the stomach, pancreas and ovary, twice as common as cervical or bladder carcinoma, and three times as common as prostatic carcinoma (Registrar General for Scotland, 1993) . Malignant brain tumours account for 10.7% of all registered deaths from cancer in people aged under 45. Although gliomas are considered highly resistant to radiation therapy or chemotherapy, there is no doubt that younger patients are more likely to respond to these modalities, and treatment can result in survival gains. While better and less toxic treatments must be pursued, it is also important to ensure that appropriate patients are referred and treated promptly. If the aim of reducing mortality from cancer under the age of 65 years is to be achieved, primary brain tumours should not be forgotten by national cancer advisory services (Aitken et al., 1994) . Clinical services in neuro-oncology should be co-ordinated at a national and regional level if any progress in reducing mortality and morbidity is to be made and the policy targets achieved. 
